Total Equity - Corcept Therapeutics Inc (NASDAQ:CORT) - Alpha Spread

Corcept Therapeutics Inc
NASDAQ:CORT

Watchlist Manager
Corcept Therapeutics Inc Logo
Corcept Therapeutics Inc
NASDAQ:CORT
Watchlist
Price: 43.93 USD 1.5% Market Closed
Market Cap: 4.8B USD
Have any thoughts about
Corcept Therapeutics Inc?
Write Note

Corcept Therapeutics Inc
Total Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Corcept Therapeutics Inc
Total Equity Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Total Equity Analysis
Latest Figures & CAGR of Competitors

Company Total Equity CAGR 3Y CAGR 5Y CAGR 10Y
Corcept Therapeutics Inc
NASDAQ:CORT
Total Equity
$596.2m
CAGR 3-Years
4%
CAGR 5-Years
15%
CAGR 10-Years
67%
Johnson & Johnson
NYSE:JNJ
Total Equity
$71.5B
CAGR 3-Years
1%
CAGR 5-Years
3%
CAGR 10-Years
-1%
Bristol-Myers Squibb Co
NYSE:BMY
Total Equity
$17B
CAGR 3-Years
-23%
CAGR 5-Years
1%
CAGR 10-Years
1%
Pfizer Inc
NYSE:PFE
Total Equity
$87.7B
CAGR 3-Years
8%
CAGR 5-Years
8%
CAGR 10-Years
1%
Merck & Co Inc
NYSE:MRK
Total Equity
$43.6B
CAGR 3-Years
9%
CAGR 5-Years
10%
CAGR 10-Years
-1%
Eli Lilly and Co
NYSE:LLY
Total Equity
$13.6B
CAGR 3-Years
28%
CAGR 5-Years
37%
CAGR 10-Years
-3%

See Also

What is Corcept Therapeutics Inc's Total Equity?
Total Equity
596.2m USD

Based on the financial report for Jun 30, 2024, Corcept Therapeutics Inc's Total Equity amounts to 596.2m USD.

What is Corcept Therapeutics Inc's Total Equity growth rate?
Total Equity CAGR 10Y
67%

Over the last year, the Total Equity growth was 41%. The average annual Total Equity growth rates for Corcept Therapeutics Inc have been 4% over the past three years , 15% over the past five years , and 67% over the past ten years .

Back to Top